Pregnancy prolongation in triplet pregnancies: Oral vs. continuous subcutaneous terbutaline

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 46, Issue 11, 2001, Pages 975-982

  Elliott, J P ^a   Bergauer, N K ^a   Jacques, D L ^a   Coleman, S K ^a   Stanziano, G J ^a  

^a Phoenix Perinatal Associates   (United States)

Author keywords

Pregnancy, prolonged; Premature labor; Terbutaline; Tocolysis; Triplets

Indexed keywords

TERBUTALINE;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE PREGNANCY; PREGNANCY; PREMATURE LABOR; PRIORITY JOURNAL; TOCOLYSIS; TREATMENT OUTCOME; UTERUS CONTRACTION;

ADMINISTRATION, ORAL; ADULT; FEMALE; GESTATIONAL AGE; HUMANS; INFUSIONS, INTRAVENOUS; OBSTETRIC LABOR, PREMATURE; PERINATAL CARE; PREGNANCY; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES; TERBUTALINE; TIME FACTORS; TOCOLYTIC AGENTS; TRIPLETS;

EID: 0035204031     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Births: Final data for 1998
2. Triplet births: Trends and outcomes, 1971-1994. Statistics
3. Aggressive perinatal care for high-order multiple gestations: Does good perinatal outcome justify aggressive assisted reproductive techniques?
4. Perinatal outcome in triplet gestation: Does prophylactic cerclage make a difference?
5. Perinatal outcome associated with outpatient management of triplet pregnancy
6. Antepartum management of triplet gestations
7. Terbutaline pump tocolysis in high-order multiple gestation
8. Evaluating treatments for preterm labor: Possible solutions for some methodological problems
9. Do tocolytic agents stop preterm labor? A critical and comprehensive review of safety and efficacy
10. Treatment of preterm labor with the beta-agonist ritodrine
11. A prospective comparison of terbutaline and magnesium for tocolysis
12. Beta-mimetics in preterm labour: An overview of the randomized clinical trials
13. Efficacy of maintenance therapy after acute tocolysis: A meta-analysis
14. The clinical efficacy of oral tocolytic therapy
15. Oral terbutaline in the outpatient management of preterm labor
16. Oral terbutaline after parenteral tocolysis: A randomized, double-blind, placebo-controlled trial
17. The contribution of low birth weight to infant mortality and childhood morbidity
18. A multicenter study of preterm birth weight and gestational age-specific neonatal mortality
19. Beta-adrenergic receptors in human myometrium during pregnancy: Changes in the number of receptors after beta-mimetic treatment
20. Risk-benefit assessment of tocolytic drugs
21. Incidence of adverse cardiopulmonary effects with low-dose continuous terbutaline infusion
22. Use of subcutaneous terbutaline pump for long term tocolysis
23. Pregnancy prolongation and route of tocolytic administration in patients with singleton gestation
24. A comparison of gestational days gained with oral terbutaline versus continuous subcutaneous terbutaline in women with twin gestations
25. Subcutaneous tocolytic infusion therapy for patients at high risk for preterm birth
26. Prevention of preterm birth: Early detection and aggressive treatment with terbutaline
27. Tocolysis for recurrent preterm labor using a continuous subcutaneous infusion pump
28. Continuous subcutaneous terbutaline pump for premature labor: Safety and efficacy
29. A placebo-controlled randomized trial of the terbutaline pump for prevention of preterm delivery
30. Terbutaline pump maintenance therapy for prevention of preterm delivery: A double-blind trial
31. Diurnal and gestational patterns of uterine activity in normal human pregnancy: The uterine activity in pregnancy working group
32. Uterine activity characteristics in multiple gestations